These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 31625485)

  • 1. Antipsychotic drugs
    Siafis S; Deste G; Ceraso A; Mussoni C; Vita A; Hasanagic S; Schneider-Thoma J; Papazisis G; Davis JM; Leucht S
    Psychol Med; 2020 Nov; 50(15):2622-2633. PubMed ID: 31625485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benzodiazepines for schizophrenia.
    Volz A; Khorsand V; Gillies D; Leucht S
    Cochrane Database Syst Rev; 2007 Jan; (1):CD006391. PubMed ID: 17253592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.
    Krzystanek M; Krupka-Matuszczyk I
    Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy, Acceptability, and Tolerability of Antipsychotics in Treatment-Resistant Schizophrenia: A Network Meta-analysis.
    Samara MT; Dold M; Gianatsi M; Nikolakopoulou A; Helfer B; Salanti G; Leucht S
    JAMA Psychiatry; 2016 Mar; 73(3):199-210. PubMed ID: 26842482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benzodiazepines alone or in combination with antipsychotic drugs for acute psychosis.
    Gillies D; Beck A; McCloud A; Rathbone J; Gillies D
    Cochrane Database Syst Rev; 2005 Oct; (4):CD003079. PubMed ID: 16235313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Olanzapine for schizophrenia.
    Duggan L; Fenton M; Rathbone J; Dardennes R; El-Dosoky A; Indran S
    Cochrane Database Syst Rev; 2005 Apr; (2):CD001359. PubMed ID: 15846619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second-generation antipsychotic drugs and short-term mortality: a systematic review and meta-analysis of placebo-controlled randomised controlled trials.
    Schneider-Thoma J; Efthimiou O; Huhn M; Krause M; Reichelt L; Röder H; Davis JM; Salanti G; Leucht S
    Lancet Psychiatry; 2018 Aug; 5(8):653-663. PubMed ID: 30042077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benzodiazepine augmentation of antipsychotic drugs in schizophrenia: a meta-analysis and Cochrane review of randomized controlled trials.
    Dold M; Li C; Gillies D; Leucht S
    Eur Neuropsychopharmacol; 2013 Sep; 23(9):1023-33. PubMed ID: 23602690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quetiapine versus other atypical antipsychotics for schizophrenia.
    Asmal L; Flegar SJ; Wang J; Rummel-Kluge C; Komossa K; Leucht S
    Cochrane Database Syst Rev; 2013 Nov; (11):CD006625. PubMed ID: 24249315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluphenazine (oral) versus atypical antipsychotics for schizophrenia.
    Sampford JR; Sampson S; Li BG; Zhao S; Xia J; Furtado VA
    Cochrane Database Syst Rev; 2016 Jul; 7(7):CD010832. PubMed ID: 27370402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aripiprazole versus other atypical antipsychotics for schizophrenia.
    Khanna P; Komossa K; Rummel-Kluge C; Hunger H; Schwarz S; El-Sayeh HG; Leucht S
    Cochrane Database Syst Rev; 2013 Feb; (2):CD006569. PubMed ID: 23450570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Olanzapine for schizophrenia.
    Duggan L; Fenton M; Dardennes RM; El-Dosoky A; Indran S
    Cochrane Database Syst Rev; 2003; (1):CD001359. PubMed ID: 12535408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risperidone versus olanzapine for schizophrenia.
    Jayaram MB; Hosalli P; Stroup S
    Cochrane Database Syst Rev; 2006 Apr; (2):CD005237. PubMed ID: 16625629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quetiapine versus typical antipsychotic medications for schizophrenia.
    Suttajit S; Srisurapanont M; Xia J; Suttajit S; Maneeton B; Maneeton N
    Cochrane Database Syst Rev; 2013 May; (5):CD007815. PubMed ID: 23728667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maintenance treatment with antipsychotic drugs for schizophrenia.
    Leucht S; Tardy M; Komossa K; Heres S; Kissling W; Davis JM
    Cochrane Database Syst Rev; 2012 May; (5):CD008016. PubMed ID: 22592725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second-generation antipsychotic drugs and short-term somatic serious adverse events: a systematic review and meta-analysis.
    Schneider-Thoma J; Efthimiou O; Bighelli I; Dörries C; Huhn M; Krause M; Reichelt L; Röder H; Furukawa TA; Davis JM; Leucht S
    Lancet Psychiatry; 2019 Sep; 6(9):753-765. PubMed ID: 31320283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risperidone versus olanzapine for schizophrenia.
    Jayaram MB; Hosalli P
    Cochrane Database Syst Rev; 2005 Apr; (2):CD005237. PubMed ID: 15846745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New generation antipsychotics for first episode schizophrenia.
    Rummel C; Hamann J; Kissling W; Leucht S
    Cochrane Database Syst Rev; 2003; (4):CD004410. PubMed ID: 14584012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aripiprazole versus placebo for schizophrenia.
    Belgamwar RB; El-Sayeh HG
    Cochrane Database Syst Rev; 2011 Aug; (8):CD006622. PubMed ID: 21833956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Olanzapine for schizophrenia.
    Duggan L; Fenton M; Dardennes RM; El-Dosoky A; Indran S
    Cochrane Database Syst Rev; 2000; (2):CD001359. PubMed ID: 10796640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.